Loading…
Based on limited metadata, this warning letter was issued to North Coast Biologics, a biologics manufacturer, on May 21, 2020. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The letter falls under FDA biologics regulatory oversight, though the specific issuing office is not identified in the metadata provided. To understand the actual compliance issues cited, review of the complete warning letter would be necessary.